Skip to main content

Table 1 Demographic Characteristics

From: Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial

 

Placebo

500 mg

2-HOBA acetate

750 mg

2-HOBA acetate

Total

Volunteers (n)

6

6

6

18

Sex: female [n (%)]

4 (67)

3 (50)

4 (67)

11 (61)

Age (y)

33.5 ± 13.6

35.2 ± 13.8

30.8 ± 11.9

33.2 ± 12.5

Height (cm)

167.6 ± 11.0

175.3 ± 11.6

169.3 ± 9.0

170.8 ± 10.6

Weight (kg)

64.2 ± 10.3

76.3 ± 9.7

70.7 ± 9.4

70.4 ± 10.6

BMI (kg/m2)

22.8 ± 1.8

24.8 ± 2.5

24.6 ± 2.2

24.0 ± 2.3

Race [n (%)]

 Black/African American

1 (17)

2 (33)

0 (0)

3 (17)

 White

5 (83)

4 (67)

6 (100)

15 (83)

Ethnicity [n (%)]

 Hispanic/Latino

1 (17)

1 (17)

0 (0)

2 (11)

 Not Hispanic/Latino

4 (80)

5 (83)

6 (100)

15 (88)

 Not Reported

1 (17)

0 (0)

0 (0)

1 (6)

  1. Data are presented as means ± SD unless otherwise noted